Comparison
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738 vs 3m Syndrome 3 C3280146
Clinical comparison between 3 Hydroxyisobutyryl Coa Hydrolase Deficiency and 3M Syndrome 3 for differential diagnosis and treatment planning.
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738
A metabolic disorder affecting the breakdown of amino acids. It may cause neurological problems, developmental delay, and metabolic disturbances. Treatment focuses on dietary management and supportive interventions.
3m Syndrome 3 C3280146
A genetic condition causing intrauterine growth restriction and postnatal short stature with distinctive facial features. Treatment focuses on growth monitoring and supportive measures.
6 comparison axes
Onset
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738
0-3
3m Syndrome 3 C3280146
0-0
Onset patterns differ
Severity
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738
severe
3m Syndrome 3 C3280146
moderate
Different severity levels
Chronic
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738
Chronic
3m Syndrome 3 C3280146
Chronic
Differing course
Communicable
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738
No
3m Syndrome 3 C3280146
No
Different transmission
Body System
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738
metabolic
3m Syndrome 3 C3280146
musculoskeletal
Same/different system
Category
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738
metabolic
3m Syndrome 3 C3280146
genetic
Different category
Bottom line
3-hydroxyisobutyryl-coa-hydrolase-deficiency-C0342738 and 3m-syndrome-3-C3280146 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738 | 3m Syndrome 3 C3280146 | Discriminating power |
|---|---|---|---|
| Growth pattern | Growth may be affected secondarily; primary picture is metabolic and neurologic. | Intrauterine growth restriction and postnatal short stature are characteristic. | High |
| Neurologic course | Developmental delay and neurologic problems may occur, with variable severity. | Primary features are skeletal and facial rather than a metabolic encephalopathy. | Moderate |
| Metabolic instability | Episodes of metabolic disturbance may accompany illness or feeding difficulty. | No established primary metabolic crisis pattern is described. | High |
When to favor each condition
Choose 3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738 when
Infant or young child with neurologic concerns and suspected metabolic disease
The supplied profile emphasizes amino-acid breakdown, neurologic problems, and metabolic disturbance.
Moderate
Abnormal metabolic testing needs specialist correlation
An abnormal result is not a diagnosis and should be interpreted with clinical and genetic data.
High
Supportive dietary planning is being considered
Management is described as dietary and supportive, but exact regimens must be individualized.
Moderate
Choose 3m Syndrome 3 C3280146 when
Prenatal growth restriction with persistent postnatal short stature
This matches the described onset and musculoskeletal growth phenotype.
Moderate
Distinctive facial features accompany proportionate growth failure
Facial findings plus growth restriction favor evaluation for 3M syndrome 3.
Moderate
Family history suggests a genetic skeletal-growth condition
The category is genetic and noncommunicable; confirmation requires appropriate testing.
Moderate
How key tests differ
| Test | 3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738 | 3m Syndrome 3 C3280146 | Interpretation |
|---|---|---|---|
| Metabolic laboratory evaluation | May suggest disordered amino-acid or valine-related metabolism; exact cutoffs are not established here. | No specific metabolic abnormality is established from the supplied data. | Abnormal results require specialist review and do not alone confirm either condition. |
| Genetic testing | May identify HIBCH-related variants when clinically indicated. | May identify variants associated with 3M syndrome 3 when clinically indicated. | Variant interpretation and parental studies belong to a genetics clinician. |
| Growth and skeletal assessment | Used to monitor secondary effects rather than define the disorder. | Serial growth measurements are central; skeletal findings may support the phenotype. | Measurements should be plotted over time and interpreted clinically. |
Prognosis comparison
3 Hydroxyisobutyryl Coa Hydrolase Deficiency C0342738
- Outcome
- Potentially severe chronic course; individual outcome is not established here.
- Factors
- Neurologic involvement, metabolic stability, and timeliness of supportive care may matter.
3m Syndrome 3 C3280146
- Outcome
- Generally described as moderate, with persistent short stature; exact outcome is not established.
- Factors
- Degree of growth restriction and associated clinical findings may influence needs.
Time frame: Both are chronic; left onset is early childhood, while right begins prenatally.
Prognosis should be individualized by clinicians; mortality and treatment response are not specified.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic impairment | May include developmental delay or other neurologic problems. Not described as the primary complication. Severity and permanence are not established by these source data. |
| Growth failure | May occur but is not the defining feature supplied. Prenatal and postnatal growth restriction are central. Causes and response to monitoring vary; no treatment dose is implied. |
| Acute decompensation | Metabolic disturbance may worsen during illness. No comparable acute metabolic course is established. Urgent clinician assessment is appropriate for concerning symptoms. |
Patient education highlights
- HighDiagnosis versus test result
An abnormal laboratory or growth finding needs confirmation; it does not by itself establish either diagnosis.
- HighWhen to seek care
Seek urgent care for poor feeding, reduced alertness, breathing difficulty, seizures, or sudden clinical change.
- MediumLong-term support
Care may include nutrition, neurology, genetics, growth monitoring, and developmental or rehabilitation support.